Our results suggested that high expression of COX‐2 in CAF may serve as a new prognostic indicator for predicting NPC metastasis and provide the possibility of targeting CAF for treating advanced NPC. This evidence concerns the gene PTGS2 and nasopharyngeal carcinoma.